Infectious and parasitic diseases create enormous health burdens, but because most of the
people suffering from these diseases are poor, little is invested in developing treatments. We …

High levels of pathogen resistance are rendering current antibiotics obsolete. Coupled with
insufficient investment in discovering new treatments, multidrug-resistant infections are an …

The fundamental challenge in the social sciences is moving from complicated correlations to
useful prediction. Progress usually reflects an interplay between theory, data, and tools. Six …

If a competent adult refuses medical treatment, physicians and public officials must respect
her decision. Coercive medical paternalism is a clear violation of the doctrine of informed …

1 result, farm support became increasingly decoupled from agricultural production. This
move coincided with a general willingness of taxpayers and consumers to continue to …

FDA approval times have declined significantly since the enactment of the Prescription Drug
User Fee Act (PDUFA) in 1992. As a result, present value expected returns to …

In India today only 35 percent of people have access to medicines. This book examines the
rise of drug prices in India, and develops a new healthcare model, which if implemented …

“It is hard to think of many industries that have contributed as much to human welfare as the
pharmaceutical industry.” This statement was made not by a pharmaceutical industry chief …

In both absolute and relative terms more official development assistance (ODA) is being
spent on climate change-related activities. Around 84 percent of bilateral climate finance is …

Few issues are as controversial as the impact of intellectual property on health in developing
countries. Activists and poor countries' governments have, for example, long claimed that …